7EL-10187-95356
4 vaccinations
3 coded responses
55 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 553 / MN
- Registered
- 2021-04-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-02
Registered in v-safe
-
2021-04-02
Dose 1 — Pfizer-BioNTech
- 2021-04-02
-
2021-04-03
Survey response — days 1–6 daily, dose 1MedDRA: Dysgeusia — Feeling: Fair · Site: Pain · Chills, Fatigue or tirednessFree text: Metallic taste in mouthMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-04
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fatigue or tiredness, NauseaAdult check-in
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-08
- 2021-04-09
- 2021-04-16
- 2021-04-23
-
2021-04-30
Dose 2 — Pfizer-BioNTech
- 2021-04-30
-
2021-05-01
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-05-02
- 2021-05-03
- 2021-05-04
-
2021-05-05
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fever · Fatigue or tirednessAdult check-in
- 2021-05-06
- 2021-05-07
- 2021-05-14
- 2021-05-21
- 2021-05-28
- 2021-06-04
- 2021-06-11
- 2021-07-30
- 2021-10-29
-
2021-12-03
Dose 3 — Pfizer-BioNTech
- 2021-12-03
-
2021-12-04
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-12-05
- 2021-12-06
- 2021-12-07
- 2021-12-08
- 2021-12-09
- 2021-12-10
- 2021-12-17
- 2021-12-24
- 2021-12-31
-
2022-01-07
Survey response — day 35, dose 3MedDRA: Cough, Oropharyngeal pain — Feeling: GoodFree text: Cough and sore throatMedDRA releases: 2024-11 · check-in free text available
- 2022-01-14
- 2022-03-04
-
2022-06-03
Survey response — 6 months, dose 3MedDRA: Ageusia, Cough — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Loss of taste, coughMedDRA releases: 2024-11 · check-in free text available
-
2022-06-03
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-06-06
-
2022-06-06
Call successfulNot applicable - Accidental Reporting
-
2022-09-16
Dose 4 — Pfizer-BioNTech
- 2022-09-16
- 2022-09-17
-
2022-09-18
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Redness, Swelling · Fever · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-09-19
- 2022-09-20
- 2022-09-21
- 2022-09-22
- 2022-09-23
- 2022-09-30
- 2022-10-07
- 2022-10-14
- 2022-10-21
- 2022-10-28
- 2022-12-16
- 2023-03-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-02 | Pfizer-BioNTech | |
| 2 | 2021-04-30 | Pfizer-BioNTech | |
| 3 | 2021-12-03 | Pfizer-BioNTech | No |
| 4 | 2022-09-16 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-06-03 | Successful 2022-06-06 |
Not applicable - Accidental Reporting |
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Metallic taste in mouth
Release 10 — day 35, dose 3
Symptoms: Cough and sore throat
Release 11 — 6 months, dose 3
Symptoms: Loss of taste, cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SRO | Dysgeusia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release